Publications by authors named "Pascal Veillon"

Claim this Profile
P
Prevalence, clinical and virological characteristics and short-term prognosis of hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania.
Hélène Le Guillou-Guillemette, Adeline Pivert, Ahmed ElBara, Mazouz Vall, Cindy Ng Wing Sang, Pascal Veillon

J Viral Hepat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A software tool to support follow-up care in a French childhood cancer cohort: construction and feasibility.
Charlotte Demoor-Goldschmidt, Pascal Veillon, Maxime Esvan, Mathilde Leonard, Sophie Chauvet

BMC Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
Yusuke Shimakawa, Pascal Veillon, Jacques Birguel, Adeline Pivert, Virginie Sauvage

Lancet Glob Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.
Ahmed El Bara, Adeline Pivert, Pascal Veillon, Cindy Ng Wing Sang, Mohamed Bollahi

Vaccine· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France.
Caroline Lefeuvre, Adeline Pivert, Hélène Le Guillou-Guillemette, Françoise Lunel-Fabiani, Pascal Veillon

J Infect· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
Hélène Le Guillou-Guillemette, Adeline Pivert, Elise Bouthry, Cécile Henquell, Odile Petsaris, Pascal Veillon

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.
Alexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, Jérôme Boursier, Viorica Balan, Pascal Veillon

J Gastroenterol Hepatol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?
Pascal Veillon, Isabelle Fouchard-Hubert, Dominique Larrey, Manh Thông Dao, Louis D'alteroche

J Interferon Cytokine Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.
Odile Petsaris, Sophie Vallet, Hélène Le Guillou-Guillemette, Pascal Veillon, Stéphanie Gouriou

J Clin Virol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
Françoise Lunel-Fabiani, Wael Mansour, Abdellahi Ould Amar, Mohamed Aye, Frédéric Le Gal, Pascal Veillon

J Infect· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.
Stéphanie Patouraux, Stéphanie Bonnafous, Cosmin S Voican, Rodolphe Anty, Marie-Christine Saint-Paul, Pascal Veillon

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania.
Wael Mansour, F-Zahra Fall Malick, Ahmad Sidiya, Elkhalil Ishagh, Mariama Abdou Chekaraou, Pascal Veillon

J Med Virol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of new hyaluronic acid assays and their impact on FibroMeter scores.
Pascal Veillon, Yves Gallois, Valérie Moal, Isabelle Fouchard-Hubert, Isabelle Charles

Clin Chim Acta· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
Paul Calès, Philippe Halfon, Dominique Batisse, Fabrice Carrat, Philippe Perré, Pascal Veillon

J Hepatol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of blood tests of liver fibrosis in clinical practice.
Paul Calès, Pascal Veillon, Anselme Konaté, Elisabeth Mathieu, Catherine Ternisien

Clin Biochem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.
Pascal Veillon, Christopher Payan, Hélène Le Guillou-Guillemette, Catherine Gaudy, Françoise Lunel

World J Gastroenterol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations within the hepatitis C virus genotype 1b E2-PePHD domain do not correlate with treatment outcome.
Catherine Gaudy, Marie Lambelé, Alain Moreau, Pascal Veillon, Francoise Lunel

J Clin Microbiol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study).
Xavier Causse, Si Nafa Si Ahmed, Jacques Gros, Veronique Loustaud-Ratti, Yannick Bacq, Pascal Veillon

Gastroenterol Clin Biol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.
Françoise Lunel, Pascal Veillon, Isabelle Fouchard-Hubert, Véronique Loustaud-Ratti, Armand Abergel

J Hepatol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome.
Catherine Gaudy, Alain Moreau, Pascal Veillon, Stephanie Temoin, Francoise Lunel

J Clin Microbiol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
Pascal Veillon, Christopher Payan, Gastón Picchio, Michèle Maniez-Montreuil, Philippe Guntz

J Clin Microbiol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis